Sepracor's Estorra Is "Approvable"; Launch Goal Is Mid-Year
This article was originally published in The Pink Sheet Daily
Executive Summary
Sepracor will resubmit its NDA for the insomnia agent in one to three months after receiving an "approvable" letter Feb. 27.